Millipore India to market veg-based recombinant insulin to bio-pharma sector soon

Millipore India which has developed a solid platform in upstream process technology, is now aggressively working to market Incelligent AF, a recombinant insulin for cell culture application that is vegetable based. 

Incelligent AF insulin is a complete animal free product used to optimize cell culture media and support animal-free regulatory filings. It does not have either bovine or porcine components.

The company has adopted a five-point definition of the term animal-free for its biologically-based cell culture supplements. There are no animal-origin components in the Master Cell Bank (MCB), working Cell Bank (WCB), raw materials, manufacturing process and final product helping to fulfil all five criteria to be labelled as 'animal free'. 


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying